Health – Tech2.Org Largest Nonprofit Digital Media. We work to Give a Voice to the powerless, to help Public & to Illuminate their lives. Wed, 13 Feb 2019 14:25:01 +0000 en-US hourly 1 New drug shows promise against several aggressive cancers – Medical News Today Wed, 13 Feb 2019 14:25:01 +0000

New drug shows promise against several aggressive cancers.

Initial trials in humans found that a new drug, tisotumab vedotin, shows significant promise in the treatment of persistent tumors in several late-stage cancers.

Source link

Brucella bacteria is found in raw milk purchased in 19 states: CDC Wed, 13 Feb 2019 14:14:22 +0000

The first infection occurred in November 2018, and by January 22, researchers had traced milk to consumers in Alabama, California, Connecticut, Florida, Georgia, Iowa, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, New Jersey , New York. North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina and Virginia.

Source link

According to one study, some foods are actually related to a higher death rate Wed, 13 Feb 2019 13:18:25 +0000

The food is full of chemicals and always has been. After all, everything is chemical products. But modern "ultra-processed" food is something else again, and new research suggests it could be more harmful than we suspect.

A new massive study by scientists in France who examined the dietary intake of more than 44,000 French adults found that consumption of ultra-processed foods, including mass-produced snacks, sugar-sweetened beverages and prepared foods, was associated with an increased risk of mortality.

"Ultra-processed foods are food products that contain multiple ingredients and are manufactured through a multitude of industrial processes," explain the researchers, led by nutritional epidemiologist Laure Schnabel of the Sorbonne University, in their article.

"These food products are generally ready to heat and eat, they are affordable and hyperpapable."

They can be convenient and tasty, but it is known that the consumption of ultra-processed foods (which also include highly processed breads, plus confectionery and processed meats) is problematic, as it has been linked to an increased risk of things like obesity, hypertension and cancer.

Until now, however, no one had evaluated separately whether eating ultra-processed foods also made you more likely to die.

In the studied cohort, however, he did.

Over a period of more than seven years, a 10 percent increase in the proportion of ultra-processed food consumption was associated with a 14 percent greater risk of all-cause mortality.

The research team is eager to emphasize that the study was only observational, so a causal effect can not be demonstrated. But the fact that a statistically significant association has been found is something to think about.

"We should not be alarmist, or say that eating a packed lunch gives you 15 percent more chance of dying," Mathilde Touvier, co-investigator of the NutriNet-Santé cohort who studied, told AFP.

"It's another step in our understanding of the link between ultra-processed food and health."

What is certain is that ultra-processed foods contain many things that are not found in whole foods: all kinds of additives, including preservatives, sweeteners, intensifiers, colors, flavors, etc.

They also contain a lot of energy: in the study, which accounts for 14.4 percent of the total weight of food and beverages consumed, but 29.1 percent of the total energy intake.

According to epidemiologist Nita Forouhi of the University of Cambridge, who was not part of the study, ultra-processed foods are also consumed disproportionately more by people with lower incomes or education levels, or those who live alone.

"A vital message to bear is that the consumption of highly processed foods reflects social inequalities," says Forouhi.

"Such foods are attractive because they tend to be cheaper, they are very tasty due to the high content of sugar, salt and saturated fats, they are widely available, they are highly commercialized, they are ready to eat, and their dates of use are long, so that last longer. "

As it stands, despite the robust size and duration of this particular investigation, there is much work to be done to finally unravel why and how ultra-processed foods can be bad for us.

It is a job that is made much more difficult due to the multitude of food products that we are talking about, not to mention the multitude of ingredients (artificial or otherwise) that contain ultra-processed foods.

"Some factors may be more harmful or less harmful than others," said nutritional scientist Nurgul Fitzgerald of Rutgers University, who was not involved in the research.

But if you're especially concerned about ultra-processed foods, what they contain and what they might be doing with you, the best approach might be to go back to basics the next time you're in the supermarket.

"Look at the list of ingredients – do you understand all the ingredients that go into your food?" Fitzgerald said. "[Buy those] with the least amount of ingredients and with ingredients that you understand. "

The findings are reported in Jama internal medicine.

Source link

The hope of Alzheimer: the memories of patients could be improved by unblocking the blood vessels of the brain Wed, 13 Feb 2019 12:40:14 +0000

Scientists believe Alzheimer's patients could improve their memory by unblocking the blood vessels in the brain.

It is known that Alzheimer's disease reduces blood flow to the brain and research has found that this could be due to white blood cells sticking to the inside of blood vessels.

And, in a study on mice, brain memory and performance improved rapidly when scientists eliminated these blockages.

According to experts, it could be a "game change" if the same mechanism is applied to the millions of people suffering from the disease worldwide.

Scientists hope that in the study of a model with mice can improve the memory of Alzheimer's patients by unblocking the blood vessels of the brain.

Scientists hope that in the study of a model with mice can improve the memory of Alzheimer's patients by unblocking the blood vessels of the brain.

Scientists hope that in the study of a model with mice can improve the memory of Alzheimer's patients by unblocking the blood vessels of the brain.

The researchers came across the finding by accident, when Nozomi Nishimura, an associate professor at the Meinig School at Cornell University, was trying to place clots in the blood vessels of the brains of Alzheimer's mice to see their effect.

"It turns out that … the blocks we were trying to induce were already there," he said.

"In some way the research changed, this is a phenomenon that was already happening."

Professor Nishimura worked with Professor Chris Schaffer over the next decade to find that only two percent of the brain capillaries had these blocks or "blocks."

But the cumulative effect of that small amount of stoppages was an overall decrease of about 20 percent in cerebral blood flow, due to the deceleration of the vessels downstream by capillaries that stagnated.

Recent studies suggest that deficits in cerebral blood flow are one of the first detectable symptoms of dementia, suggesting that this could also be useful for diagnosis.

To test his theory that white blood cells were stuck inside the capillaries, the smallest blood vessels in the brain, the team "unblocked" the vessels.

They gave an antibody to mice with Alzheimer's that interfered with the adhesion of white blood cells to the capillary walls.


AThe disease of Lzheimer is a progressive and degenerative disease of the brain, in which the accumulation of abnormal proteins causes the nerve cells to die.

This interrupts the transmitters that carry messages and causes the brain to contract.

More than 5 million people suffer from the disease in the United States. UU., Where is the sixth cause of death.


As brain cells die, the functions they provide are lost.

That includes memory, orientation and the ability to think and reason.

The progress of the disease is slow and gradual.

On average, patients live five to seven years after diagnosis, but some can live for ten to 15 years.


  • Loss of short-term memory.
  • Disorientation
  • Behavior changes
  • Humor changes
  • Difficulty handling money or making a phone call.


  • Severe memory loss, forgetting close relatives, familiar objects or places
  • Being anxious and frustrated by the inability to make sense of the world, leading to aggressive behavior
  • Eventually you will lose the ability to walk.
  • You may have trouble eating
  • Most will eventually need 24-hour care.

Source: Alzheimer's Association

This increased blood flow to the brain, said the findings, published in Nature Neuroscience.

This improved memory function in a few hours, even in older mice with more advanced stages of Alzheimer's disease.

Although it worked in mice, the team has yet to find out if it could work with humans.

An antibody could not be used in humans, and interfering with the adhesion of white blood cells would affect the immune system of an individual.

"What we have done is to identify the cellular mechanism that causes the reduction of cerebral blood flow in models of Alzheimer's disease, which are neutrophils. [white blood cells] getting into the capillaries, "said Professor Schaffer.

& # 39; We have shown that when we block the cellular mechanism [that causes the stalls], we obtain an improved blood flow, and associated with that improved blood flow is the immediate restoration of the cognitive performance of spatial and working memory tasks.

"Now that we know the cellular mechanism, it's a much narrower path to identify the drug or the therapeutic approach to treat it."

Approximately 20 medications, many of them already approved by the FDA for human use, have been identified as potential in the treatment of dementia.

However, some of them were designed to be taken in high doses for short periods of time to treat sepsis, or immediately after a heart attack or stroke.

Although they are not ideal for long-term use, Professor Schaffer said they are still testing these drugs in mice with Alzheimer's now.

Professor Schaffer said he is "super-optimistic" that if the same mechanism of capillary blockage is at stake in humans than in mice, this line of research "could be a complete change for people with Alzheimer's disease" .

It is believed that Alzheimer's disease is caused by the abnormal accumulation of proteins in and around brain cells.

Research has shown that many people with Alzheimer's also have damage to the blood vessels in the brain, which leads to the belief that this damage to the blood vessels can affect the progression of the disease in its early stages.

Research has found that a reduction in blood flow prevents brain cells from receiving the oxygen and nutrients they need, possibly harming memory even more.

Alzheimer's disease is the most common type of dementia, affecting 62% of the 850,000 people diagnosed in the United Kingdom.

Source link

PETA supporters dress up with & # 39; sexy underwear & # 39; and they embrace outdoors in downtown Nashville Wed, 13 Feb 2019 12:01:30 +0000

5 and Broadway in downtown Nashville. PHOTO: FOX 17 News

NASHVILLE, Tenn .– Two PETA supporters plan a public display of affection snuggling in a bed in Nashville.

According to a statement from the organization, the two supporters will wear "sexy underwear" with heart-shaped posters that read "Vegans Make Better Lovers."

PETA says the movement is an effort to "remind those eager to please their partners that eating meat can hurt time in the bedroom, by reducing the flow of blood to all the organs of the body."

The statement said that those who become vegans "save almost 200 animals a year" and those who eat meat have "higher rates of heart disease, stroke, diabetes, obesity and cancer"

The exhibition will be held on 5th Avenue and Broadway on Wednesday at noon.

Source link

La Porte Elementary investigates suspected case of measles Wed, 13 Feb 2019 11:45:20 +0000

LA PORTE, Texas (KTRK) –

A suspected case of measles is under investigation at La Porte Elementary School, according to a letter sent to parents on Tuesday.

According to La Porte ISD, it is working with the Harris County Public Health Department to "take all necessary measures to ensure the welfare of our students" and "as a precaution, we are disinfecting all classrooms and common areas of the campus" .

District communications director Terri Cook said students are expected to attend school as usual on Wednesday, which is a scheduled early release day.

The student with the suspected case is in pre-kindergarten. No other information was published due to privacy laws.

"It is commonly spread by going to another country and coming in contact with unvaccinated people or people traveling here from countries where vaccination is not as frequent," said Davita Hall, a mother and nurse practitioner at AFC Urgent Care in La Porte. "We simply advise people to vaccinate their children against measles."

Earlier this month, health officials in Harris, Montgomery and Galveston counties reported at least one confirmed case of the disease.

According to Montgomery County officials, a 2-year-old girl is recovering from the disease. They also said that this case is related to one of the Harris County cases, but the details of the connection were not disclosed immediately.

The Galveston County Health District also confirmed a case involving a child whose age ranges between 12 and 24 months. The boy was examined on January 28 and officials said the case is part of a group in the region.

Earlier on Monday, the Harris County Public Health Department said two children under the age of two and a woman between the ages of 25 and 35 were diagnosed with measles. All three patients live in northwest Harris County.

Measles is a highly contagious virus that is transmitted by direct contact or by air.

Symptoms include high fever, cough, runny nose and red and watery eyes between seven and 14 days after infection, says the US National Library of Medicine. UU
However, measles is preventable.

Health officials are encouraging everyone to protect themselves from the virus by getting vaccinated.

Follow Jessica Willey on Facebook and Twitter.

SEE MORE: What is measles? What you need to know about the symptoms of measles, vaccine and treatment.

RELATED: Does it cause concern? Texas among the states with the highest rates of children who are not vaccinated

(Copyright © 2019 KTRK-TV. All rights reserved.)

Source link

In a small brain cancer study, immunotherapy produces a prolonged survival Wed, 13 Feb 2019 10:49:09 +0000

SunResearchers reported in a study published Monday that patients with lethal brain tumors, a new and powerful form of cancer treatment before undergoing surgery, helped them live longer on average than patients who started taking the drugs. after surgery.

While the study was small, and while most patients still died at the end of the study period, the researchers said the results suggest that time could be an important factor when it comes to treating glioblastoma, or GBM, with immunotherapies, which are designed to release the immune system. System of cancer cells. Previous attempts to use immunotherapies to help patients with GBM have not achieved broad clinical benefits, and any positive result is striking with a cancer as formidable as GBM, which has an average survival time of only a few years.

"At least we've found a window," said Robert Prins, a tumor immunologist at the Jonsson Comprehensive Cancer Center at UCLA and lead author of the paper. "We had not seen anything before, now I think we're seeing a signal."


External experts echoed Prins, noting that it was a randomized trial The patients were divided into different treatment groups to compare the results, which gives more weight to the findings. While they cautioned that many of the initially interesting study results are not supported by wider research, they said the study, which was published in the journal Nature Medicine, laid the groundwork for research that would combine different immune boosting strategies at this time. in a patient. disease.

"It's exciting because up until now, the immunotherapies seemed to be on the way to everything else:" Oh, they work on peripheral tumors, but not in the brain, "said Dr. Frederick Lang, president of neurosurgery at the MD Anderson Cancer Center, which was not involved in the research. "This study really instills hope in the field, that these checkpoint inhibitors can be effective if we use them correctly," he added, referring to the type of immunotherapy used in the trial.

The study focused on 32 patients with recurrent GBM: people who already had a first round of treatment (GBM is initially treated with surgery, radiation and a chemotherapy called temozolomide) and whose cancers began to grow again. For the study, half of them started with a checkpoint inhibitor before undergoing surgery to remove as much growth tumor as possible, and the other half waited to start the medication until after the surgery.

Patients in the first group had a mean survival of 417 days, while patients in the second group had a median survival of 228 days. Patients who received the medication before surgery also lasted longer before the tumor started to progress again.

The research was conducted in seven centers from October 2016 to September 2017. In July 2018, when the researchers stopped tracing them for the study, 12 of the patients in the late-onset group had died and nine of the previous-start group had died. died.

By awakening immune cells and knocking down the defenses of cancer cells, immunotherapies have allowed remarkable recoveries for some patients with some cancers. But brain tumors have proven to be one of the most difficult cancers to detect. In December, two research teams reported that they could generate a promising immune response in patients with GBM with another type of immunotherapy called neoantigenic vaccine, but that did not lead to better outcomes for patients.

Brain tumors are particularly difficult to treat for several reasons. It is difficult for medicines in general to penetrate the brain. More specifically, brain tumors do not have as many genetic vulnerabilities for cancer therapies as other tumors. They are also able to control the immunological activity, which turns them into the so-called immunologically cold cancers.

In this study, the researchers tested a checkpoint inhibitor. Control points are one of the ways in which cancer prevents immune cells from destroying tumor cells, so inhibitors work by interfering with these checkpoints. The study used pembrolizumab, which blocks the PD-1 checkpoint and is approved for some forms of cancer such as Keytruda. (Merck, who makes Keytruda, provided the medication for the study).

The researchers initially designed the study only as a scientific survey to compare what happened to the immune system and the tumor in different groups of patients; they did not expect to discover an apparent clinical benefit at the time of the treatments.

"The original idea was to really understand what PD-1 blockage does to the tumor microenvironment, which makes the immune response to the tumor in the brain," said Prins, who is also affiliated with the Parker Institute for cancer immunotherapy.

The researchers are not sure why patients who received pembrolizumab before surgery lived longer, but it is possible that providing the medication and surgery in that order was one or two strokes. Perhaps, according to experts, the drug must be activated by being exposed to proteins on the outside of the tumor cells called antigens, which act as small flags that identify the invaders that the immune system should attack. Then, when the tumor was removed, the curtain of immunosuppression that supports the tumor was dropped, so that the drug could invade the cells left by the surgery.

When the researchers looked at what was going on inside the immune and tumor cells, they found that in the patients who received the medication before surgery, the immune cells were prepared to attack and kill the cancer cells, while their cancer cells were more slow to copy.

But even if these patients lived longer, most of them had still died before the study's end date. Dr. Hideho Okada, director of the brain tumor immunotherapy program at the University of California, San Francisco, compared GBM to a car with a lot of problems: brakes, transmission, the engine, etc. A PD-1 inhibitor such as pembrolizumab is only designed to solve one of these problems, but cancer has many other problems that must be addressed in order for the tumor to be completely eliminated.

"To make the car start working safely again, you have to solve each of these problems," said Okada, who was not involved in the study. "PD-1 is addressing a mechanism, so to take advantage of this preliminary success, we have to plan rational combinations of immunotherapy drugs."

Source link

Vapear is erasing the advances made against tobacco use among American adolescents. Wed, 13 Feb 2019 10:42:00 +0000

E-cigarettes have eliminated previous progress in reducing the use of tobacco products among teenagers, US health officials said on Monday. UU

About 4.9 million high school and high school students were current users of a tobacco product in 2018, compared to 3.6 million in 2017, according to the results of the National National Youth Tobacco Survey.

In all, more than 1 in 4 high school students and about 1 in 14 high school students used a tobacco product in 2018, according to data from the US Centers for Disease Control and Prevention. UU

The researchers attributed this increase entirely to electronic cigarettes, noting that no significant change was found in the use of any other tobacco product, including traditional tobacco cigarettes.

"The vertiginous increase in the consumption of electronic cigarettes by young people over the past year threatens to eliminate the progress made in reducing tobacco use by young people, putting a new generation at risk of nicotine addiction," said the director of the CDC, Dr. Robert Redfield, in a statement.

According to previous studies cited by the CDC, children who use electronic cigarettes are more likely to progress to tobacco smoking after becoming hooked on nicotine.

Strong evidence

Nicotine in electronic cigarettes also presents other health hazards, said Dr. Anne Schuchat, the CDC's principal deputy director.

"Nicotine is highly addictive and can damage brain development, including the damaging effects on learning, memory and attention," said Schuchat. Nicotine also prepares the brain for addiction to other substances, he added.

Matthew Myers, president of the Campaign for Tobacco Free Kids, called the survey results "deeply disturbing."

"These results are strong evidence that e-cigarettes are not helping to reduce cigarette consumption in young people," said Myers. "In fact, in any case, the evidence to date indicates that electronic cigarettes could increase the number of children who smoke."

The CDC found that there were 1.5 million more young users of electronic cigarettes in 2018 than in 2017, and those who vaped it did so more often.

The consumption of electronic cigarettes increased to almost 21% among high school students and 5% among high school students in 2018, an increase of approximately 12% and 3% in 2017, respectively.

The proportion of high school students who vaped at least 20 of the past 30 days increased to 28% in 2018 from 20% the previous year, the CDC added.

Attractive flavors

The agency specifically mentioned the e-cigarette JUUL in its report, noting that the increase in youth vaping reflected the increase in JUUL sales.

The JUUL is shaped like a USB flash drive and is easy to hide, the CDC noted. It uses nicotine liquid refills called "pods" that contain at least as much nicotine as a pack of cigarettes, and are available in flavors that appeal to teens.

"JUUL entered the US market in 2015 and since December 2017 has had the largest market share of all electronic cigarettes in the US We know that JUUL devices are used among school children, including the bathrooms and the classrooms, "said Brian King. , deputy director of the Office of Smokers and Health of the CDC.

"JUUL also has a high nicotine content, one of the highest of all electronic cigarettes in the US market," King continued. "The devices also use nicotine salts, which can allow large amounts of nicotine to be inhaled more easily and with less irritation than the free base nicotine that is used in most other electronic cigarettes."

For the fifth year in a row, electronic cigarettes were the most widely used tobacco product among high school students. Cigarettes (8%) were the most common, followed by cigarettes (7%), smokeless tobacco (6%), narghile (4%) and pipe tobacco (1%).

And many children are not limited to one type of tobacco product, according to the CDC.

Among current tobacco users, approximately 2 in 5 (1.7 million) high school students and 1 in 3 (270,000) high school students used two or more tobacco products in 2018. The combination of tobacco products more Commonly used was e-cigarettes and tobacco cigarettes. among high school and high school students.

The findings were published on February 11 in the CDC publication. Vital signs.

A quick action is needed

The US Food and Drug Administration UU It is cracking down on e-cigarette marketing and sales targeting teens, but much remains to be done, said Thomas Ylioja, clinical director of health initiatives at National Jewish Health in Denver.

"Vaping products managed to evade regulations that reduced the initiation of tobacco use by young people for more than 20 years, including age restrictions on purchases accompanied by fines to retailers, advertising bans, taxes to increase the price and the restriction of the use of products indoors, "said Ylioja said.

"Lawmakers and legislators are responding, but we need quick action to ban advertising to young people, including through social media, restrict online purchases, increase the age of purchase of nicotine products to 21 years, prohibit the Vaping in places where tobacco is prohibited, and "Make sure that nicotine vaping products are taxed like other tobacco products," he continued.

Image credit: iStock

Source link

STUDY: drugs that help people addicted to opioids are more difficult to obtain Wed, 13 Feb 2019 10:36:02 +0000

by Keaton Thomas, KATU News

The opioid epidemic has grown. The chances of you dying from an accidental overdose of opioid drugs are greater than those of a car accident. Still, researchers at Oregon Health & Science University say it is more difficult to obtain a potentially useful medication for people with opioid use disorder.

The drug we are talking about is called buprenorphine. Doctors say it helps prevent withdrawal symptoms.

Researchers from OHSU published their study in the Journal of the American Medical Association on Tuesday. They reviewed the Medicare Part D insurance plans and found that 89 percent of the plans covered unrestricted buprenorphine in 2007, but that it was reduced to 35 percent in 2018.

Buprenorphine is covered by most insurance plans, according to the OHSU study.

Dan Hartung, the lead author and professor of the School or Pharmacy OSU / OHSU, told KATU. The restrictions of the news could mean that a patient can not get his prescription for a few hours or a few days.

He estimates that there are 300,000 people with opioid use disorder with Medicare Part D.

"This is critical for these people to have access to this medication because they may be vulnerable to re-use illicit drugs, relapse or things like that," Hartung said. "Any delay like this is going to be problematic for patients."

The authors wrote: "The reasons for the restrictions on buprenorphine may reflect inaccurate perceptions of drug risk, social norms related to the stigma of addiction or financial considerations."

Todd Korthuis, who specializes in the treatment of addiction at OHSU, says that buprenorphine helps people with opioid use disorder feel normal again.

"It frees them from that change of ups and downs with the use of heroin and allows them to get their lives back," Korthuis said.

Korthuis generally recommends that people use buprenorphine for about a year. He says that people can use the "cold turkey" or use buprenorphine to detoxify quickly, but it is not as effective.

"Cravings often return immediately, the risk of overdose and death from their next use of heroin increases dramatically." Buprenorphine removes that by creating a normal situation, such as the one that would create insulin for someone having an episode of diabetic hypoglycemia. said Korthuis.

Cathryn Donaldson, spokeswoman for America's Insurance Insurance Plans, a defense group of health insurance companies, told KATU News that everyone should have access to the drugs they need.

The main restriction cited in the study was prior authorization for the medication.

Donaldson said in a statement: "Medical management tools, such as prior authorization, mean the safe and effective use of MAT. These tools can also ensure that the patient's progress is monitored and that the treatment plan is adjusted when necessary. It is important to keep in mind that medical management approaches may vary between health insurance providers and between private insurance and public programs. "

Source link

According to a study, eating "ultra-processed" foods accelerates the risk of premature death Wed, 13 Feb 2019 10:25:20 +0000

CNN) – According to new research from France, the quick and easy noses you love are reducing your mortality one bite at a time: we face a 14 percent higher risk of premature death with every 10 percent increase in the amount of ultra-processed foods that we eat

"Ultra-processed foods are manufactured industrially from multiple ingredients that generally include additives used for technological and / or cosmetic purposes," the authors wrote.


Published on Monday in the journal JAMA Internal Medicine. "Ultra-processed foods are mainly consumed in the form of sandwiches, desserts or ready-to-eat or hot meals," and their consumption "has increased greatly during the last decades."

This trend can lead to an increase in premature deaths due to chronic diseases, such as cancer and cardiovascular diseases, they say.

Ultra-processed foods are gaining ground in our diets.

In the United States, 61 percent of an adult's total diet comes from ultra-processed foods, in Canada, it's 62 percent, and in the United Kingdom, that proportion is 63 percent, a

recent study

he found. However, research also indicates that eating ultra-processed foods can cause obesity, high blood pressure and cancer, according to the study authors.

To understand the relationship between ultra-processed foods and the risk of death earlier than expected, the researchers sought the help of 44,551 French adults aged 45 and over for two years. Their average age was 57 years, and almost 73 percent of the participants were women. All provided 24-hour dietary records every six months, in addition to completing questionnaires about their health (including body mass index and other measurements), physical activities and sociodemographic data.

The researchers calculated the overall dietary intake of each participant and the consumption of ultra-processed foods.

They found that ultra-processed foods accounted for more than 14 percent of the total weight of food consumed and about 29 percent of total calories. The consumption of ultra-processed foods was associated with a younger age, lower income, lower educational level, life alone, higher BMI and lower level of physical activity.

During the study period, 602 participants died. After adjusting factors such as smoking, the researchers calculated an associated 14 percent higher risk of early death for each 10 percent increase in the proportion Of ultra-processed food consumed.

More studies are needed to confirm these results, the authors say. However, they speculate that additives, packaging (chemical products are introduced into food during storage) and processing itself, including high-temperature processing, may be the factors that adversely affect health.

Read the pack from front to back

The "findings make sense, given what we know to date about the harmful effects of food additives on brain function and health, but the effects observed are very small," wrote Molly Bray, president of the Department of Nutrition Sciences. from the University of Texas. in Austin, in an email. She was not involved in the investigation.

Nurgul Fitzgerald, associate professor in the Department of Nutritional Sciences at Rutgers, State University of New Jersey, offered "congratulations to the authors" for a study that is "solid" in terms of design.

However, "ultraprocess" is a huge category of foods, and putting so many together, the researchers lost sensitivity in their results and can not identify exactly what is causing the effect observed in the study, said Fitzgerald, who was not involved in the research. . investigation.

"Some factors may be more harmful or less harmful than others, it's really too complex," he said, adding that we can not "run with" these results.

Why do people eat more of these processed foods?

"We are living in a fast world and people are looking for convenient solutions, we are always stretched out over time," Fitzgerald said. "People are looking for quick solutions, fast food."

When selecting foods, taste is the No. 1 factor for most consumers, he said, but price and convenience are also important, and with ultra-processed foods, that convenience factor is "probably the highest of the list: take and go, ready to eat. "

Fitzgerald recommends that people look not only at the front of a package when they buy prepared foods, but also at the back.

"Look at the list of ingredients – do you understand all the ingredients that go into your food?" she asked. Buy only those products "with the least amount of ingredients and with ingredients that you understand".

The CNN-Wire
™ & © 2019 Cable News Network, Inc., a Time Warner company. All rights reserved.

Source link